These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34017116)

  • 1. Therapeutic trials in adult FSGS: lessons learned and the road forward.
    De Vriese AS; Wetzels JF; Glassock RJ; Sethi S; Fervenza FC
    Nat Rev Nephrol; 2021 Sep; 17(9):619-630. PubMed ID: 34017116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
    Schwartz MM
    Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are we missing in the clinical trials of focal segmental glomerulosclerosis?
    Zand L; Glassock RJ; De Vriese AS; Sethi S; Fervenza FC
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i14-i21. PubMed ID: 28391338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of focal segmental glomerulosclerosis.
    Jefferson JA; Shankland SJ
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal Segmental Glomerulosclerosis.
    Suresh V; Stillman IE; Campbell KN; Meliambro K
    Adv Kidney Dis Health; 2024 Jul; 31(4):275-289. PubMed ID: 39084753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.
    Gbadegesin R; Lavin P; Foreman J; Winn M
    Pediatr Nephrol; 2011 Jul; 26(7):1001-15. PubMed ID: 21110043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
    Müller-Deile J; Sarau G; Kotb AM; Jaremenko C; Rolle-Kampczyk UE; Daniel C; Kalkhof S; Christiansen SH; Schiffer M
    Sci Rep; 2021 Feb; 11(1):4577. PubMed ID: 33633212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS; Han BG; Choi SO; Cha SK
    Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.
    Shabaka A; Tato Ribera A; Fernández-Juárez G
    Nephron; 2020; 144(9):413-427. PubMed ID: 32721952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology of focal segmental glomerulosclerosis: new developments.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
    Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
    Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach.
    Moriconi L; Lenti C; Puccini R; Pasquariello A; Rindi P; Batini V; Carraro M; Zennaro C
    Ren Fail; 2001; 23(3-4):533-41. PubMed ID: 11499567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.